Literature DB >> 18388859

Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis.

Thorsten Fritzius1, Karin Moelling.   

Abstract

We have previously identified a protein, consisting of seven WD-repeats, forming a putative beta-propeller, and an FYVE domain, ProF, which is highly expressed in 3T3-L1 cells, a cell line that can be differentiated into adipocytes. We recently found ProF to interact with the kinases Akt and protein kinase Czeta. Here we demonstrate that ProF is a positive regulator of adipogenesis. Knockdown of ProF by RNA interference leads to decreased adipocyte differentiation. This is shown by reduced lipid accumulation, decreased expression of the differentiation markers PPARgamma and C/EBPalpha, and reduced glucose uptake in differentiated cells. Furthermore, ProF overexpression leads to increased adipogenesis. ProF binds to the transcription factor Foxo1 (Forkhead box O1), a negative regulator of insulin action and adipogenesis, and facilitates the phosphorylation and thus inactivation of Foxo1 by Akt. Additionally, dominant-negative Foxo1 restores adipogenesis in ProF knockdown cells. Thus, ProF modulates Foxo1 phosphorylation by Akt, promoting adipocyte differentiation. Furthermore, ProF might be involved in metabolic disorders such as diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388859      PMCID: PMC2374844          DOI: 10.1038/emboj.2008.67

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

Review 1.  Transcriptional control of adipogenesis.

Authors:  S M Rangwala; M A Lazar
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

2.  C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway.

Authors:  Evan D Rosen; Chung-Hsin Hsu; Xinzhong Wang; Shuichi Sakai; Mason W Freeman; Frank J Gonzalez; Bruce M Spiegelman
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

Review 3.  Regulated transport of the glucose transporter GLUT4.

Authors:  Nia J Bryant; Roland Govers; David E James
Journal:  Nat Rev Mol Cell Biol       Date:  2002-04       Impact factor: 94.444

4.  Inhibition of adipogenesis by Wnt signaling.

Authors:  S E Ross; N Hemati; K A Longo; C N Bennett; P C Lucas; R L Erickson; O A MacDougald
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

Review 5.  Modulation of the protein kinase activity of mTOR.

Authors:  J C Lawrence; T A Lin; L P McMahon; K M Choi
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

6.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation.

Authors:  Jun Nakae; Tadahiro Kitamura; Yukari Kitamura; William H Biggs; Karen C Arden; Domenico Accili
Journal:  Dev Cell       Date:  2003-01       Impact factor: 12.270

Review 7.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

8.  Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding.

Authors:  Xiaohui Zhang; Lixia Gan; Haiyun Pan; Shaodong Guo; Xiaowei He; Steven T Olson; Andrew Mesecar; Stephen Adam; Terry G Unterman
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

9.  Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2.

Authors:  Xiao-Ding Peng; Pei-Zhang Xu; Mei-Ling Chen; Annett Hahn-Windgassen; Jennifer Skeen; Joel Jacobs; Deepa Sundararajan; William S Chen; Susan E Crawford; Kevin G Coleman; Nissim Hay
Journal:  Genes Dev       Date:  2003-06-01       Impact factor: 11.361

10.  Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors.

Authors:  Marta L Hribal; Jun Nakae; Tadahiro Kitamura; John R Shutter; Domenico Accili
Journal:  J Cell Biol       Date:  2003-08-18       Impact factor: 10.539

View more
  12 in total

1.  Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.

Authors:  Mini P Sajan; Robert A Ivey; Mackenzie C Lee; Robert V Farese
Journal:  J Lipid Res       Date:  2014-11-13       Impact factor: 5.922

2.  BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.

Authors:  Mini P Sajan; Robert A Ivey; Robert V Farese
Journal:  Metabolism       Date:  2015-08-24       Impact factor: 8.694

3.  Isoform-specific regulation of Akt signaling by the endosomal protein WDFY2.

Authors:  Helena A Walz; Xiarong Shi; My Chouinard; Catherine A Bue; Deanna M Navaroli; Akira Hayakawa; Qiong L Zhou; Jonathan Nadler; Deborah M Leonard; Silvia Corvera
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

4.  Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA.

Authors:  Louis-Marie Charbonnier; Erin Janssen; Janet Chou; Toshiro K Ohsumi; Sevgi Keles; Joyce T Hsu; Michel J Massaad; Maria Garcia-Lloret; Rima Hanna-Wakim; Ghassan Dbaibo; Abdullah A Alangari; Abdulrahman Alsultan; Daifulah Al-Zahrani; Raif S Geha; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2014-11-17       Impact factor: 10.793

5.  Predicted gene expression in ancestrally diverse populations leads to discovery of susceptibility loci for lifestyle and cardiometabolic traits.

Authors:  Heather M Highland; Genevieve L Wojcik; Mariaelisa Graff; Katherine K Nishimura; Chani J Hodonsky; Antoine R Baldassari; Alanna C Cote; Iona Cheng; Christopher R Gignoux; Ran Tao; Yuqing Li; Eric Boerwinkle; Myriam Fornage; Jeffrey Haessler; Lucia A Hindorff; Yao Hu; Anne E Justice; Bridget M Lin; Danyu Lin; Daniel O Stram; Christopher A Haiman; Charles Kooperberg; Loic Le Marchand; Tara C Matise; Eimear E Kenny; Christopher S Carlson; Eli A Stahl; Christy L Avery; Kari E North; Jose Luis Ambite; Steven Buyske; Ruth J Loos; Ulrike Peters; Kristin L Young; Stephanie A Bien; Laura M Huckins
Journal:  Am J Hum Genet       Date:  2022-03-08       Impact factor: 11.043

6.  Localization of phosphatidylinositol (3,4,5)-trisphosphate to phagosomes in entamoeba histolytica achieved using glutathione S-transferase- and green fluorescent protein-tagged lipid biosensors.

Authors:  Yevgeniya A Byekova; Rhonda R Powell; Brenda H Welter; Lesly A Temesvari
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

Review 7.  Hepatic Atypical Protein Kinase C: An Inherited Survival-Longevity Gene that Now Fuels Insulin-Resistant Syndromes of Obesity, the Metabolic Syndrome and Type 2 Diabetes Mellitus.

Authors:  Robert V Farese; Mackenzie C Lee; Mini P Sajan
Journal:  J Clin Med       Date:  2014-07-07       Impact factor: 4.241

8.  CDKN2D-WDFY2 is a cancer-specific fusion gene recurrent in high-grade serous ovarian carcinoma.

Authors:  Kalpana Kannan; Cristian Coarfa; Kimal Rajapakshe; Shannon M Hawkins; Martin M Matzuk; Aleksandar Milosavljevic; Laising Yen
Journal:  PLoS Genet       Date:  2014-03-27       Impact factor: 5.917

9.  Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesis.

Authors:  Lei Zhang; Carol Paddon; Mark D Lewis; Fiona Grennan-Jones; Marian Ludgate
Journal:  J Endocrinol       Date:  2009-05-21       Impact factor: 4.286

10.  Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity.

Authors:  Mini P Sajan; Mildred E Acevedo-Duncan; Mary L Standaert; Robert A Ivey; Mackenzie Lee; Robert V Farese
Journal:  Diabetes       Date:  2014-04-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.